Find a trial

Our clinical trials database will help you look for a clinical trial that might be suitable for you. We hope this helps you to make informed decisions and choices about your lymphoma treatment and care.

Questions about Lymphoma TrialsLink and how to use it? Read more about Lymphoma TrialsLink here or if you have a general question about clinical trials in the UK or Lymphoma TrialsLink, please contact us at trialslink@lymphoma-action.org.uk.

Note: We are not able to refer people to specific trials. If you’re interested in taking part in a trial you have found on Lymphoma TrialsLink, we recommend that you print the trial summary and discuss it with your consultant. They can advise you on whether you might be eligible for the trial and how you can take part based on your individual circumstances.

Type of lymphoma

Lymphoma status

Previously treated

Refractory

Relapsed

Untreated

Trials added in past 12 weeks

Clear filter

Trial name	Closing date Sort ascending
FRACTALL: A phase 1 trial of CAR-T cell treatment in people with T cell lymphoma	1 Dec 2042
EPCORE FL-2: A phase 3 trial of epcoritamab with rituximab and lenalidomide in people with untreated follicular lymphoma	1 Nov 2037
BELLWAVE-010: A phase 3 trial of nemtabrutinib and venetoclax in people with relapsed or refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma	1 Jun 2035
SOUNDTRACK-D2: A study to test AZD0486 first line therapy for elderly or unfit people with large B-cell lymphoma	28 Jul 2033
waveLINE-011: a phase 2 trial testing zilovertamab with R-CHP in adults with untreated DLBCL	16 Sep 2032
Bellwave-011: A phase 3 trial of nemabrutinib in people with chronic lymphocytic leukaemia or small lymphocytic lymphoma	7 Sep 2032
RADAR: A phase 3 trial of an antibody treatment called brentuximab vedotin in people with early stage Hodgkin lymphoma	1 Sep 2032
SOUNDTRACK-C1: A study of surovatamig as consolidation therapy in participants with CLL or SLL with unmutated immunoglobulin heavy chain variable (IGHV)	5 Apr 2032
BGB-11417-302: a phase 3 trial testing sonrotoclax with zanubrutinib in adults with relapsed or refractory mantle cell lymphoma	30 Mar 2032
CELESTIAL-RRCL: a phase 3 trial testing the treatment sonrotoclax in adults with relapsed or refractory CLL/SLL	31 Dec 2031
REFRACT: A phase 2 trial comparing new treatments to standard treatment in relapsed or refractory follicular lymphoma	30 Nov 2031
Soundtrack-F1: A phase 3 trial of Surovatamig (AZD0486) with rituximab in people with untreated follicular lymphoma	26 Nov 2031
ABBV-291: A phase 1 trial of ABBV 291 in people with relapsed or refractory non-Hodgkin lymphoma	1 Nov 2031
BGB-11417-304: A study to investigate sonrotoclax plus zanubrutinib compared with venetoclax plus acalabrutinib in adults with CLL	1 Nov 2031
STATIC: A study comparing intermittent and continuous treatment with ibrutinib in CLL/SLL	1 Sep 2031
Glo-BNHL: a phase 2 and 3 trial testing odronextamab and loncastuximab tesirine in young people with relapsed or refractory B-cell non-Hodgkin lymphoma	1 May 2031
NVG-222: A phase 1 and 2 trial of NVG-222 in people with relapsed or refractory lymphomas	31 Oct 2030
DAYbreak CLL-201: A phase 2 trial of NX-5948 in people with relapsed or refractory CLL/SLL	1 Oct 2030
ALLELE: A phase 3 trial of a targeted treatment called tabelecleucel in people with post-transplant lymphoproliferative disorder	1 Aug 2030
GOLSEEK-4: A phase 3 trial of golcadomide with rituximab in people with relapsed or refractory follicular lymphoma	31 Jul 2030
RAINBOW: a randomised, phase 2/3 trial comparing ibrutinib plus rituximab with standard treatment in people with Waldenström’s macroglobulinaemia	1 Mar 2030
BO43243: A phase 1 trial of mosunetuzumab in relapsed or refractory chronic lymphocytic leukaemia (CLL)	28 Feb 2030
CPI-0209: A study of CPI-0209 in relapsed or refractory diffuse large B-cell and peripheral T-cell lymphomas	27 Feb 2030
CaDAnCe-302: a phase 3 trial testing the treatment BGB-16673 in adults with CLL/SLL who have previously had a BTK and BCL2 inhibitor.	14 Feb 2030
Athena 1: A phase 1 study of REGN5837 in people with relapsed or refractory B-cell non-Hodgkin lymphomas	13 Jan 2030
ALETA-001: A phase 1 and 2 trial of ALETA-001 in patients with relapsed or refractory non-Hodgkin lymphoma	21 Dec 2029
CaDAnCe-101: A phase 1 and 2 trial of the treatment BGB-16673 in people with B-cell lymphomas	1 Dec 2029
OLYMPIA-1: A phase 3 trial of odronextamab in people with untreated follicular lymphoma	3 Nov 2029
PETReA Plus: A observational study of treatment and outcomes for people with newly diagnosed follicular lymphoma	31 Oct 2029
Determine trial treatment arm 1: A phase 2/3 trial of alectinib in people with ALK positive lymphomas	1 Oct 2029
CO43805: A Phase 1b trial of mosunetuzumab or glofitamab in people with B-cell Non-Hodgkin Lymphoma	15 Sep 2029
OLYMPIA-3: A phase 3 trial of odronextamab in people with diffuse large B-cell lymphoma	12 Sep 2029
SOUNDTRACK-B: a phase 2 trials of surovatamig in people with relapsed or refractory B-cell non-Hodgkin lymphoma	14 Jun 2029
PRIMAVERA: a phase 1/2 trial testing AZD3470 in people with relapsed or refractory lymphoma	30 Apr 2029
LIGHTBEAM-U01 (substudy 01A): a phase 1 and 2 trial testing zilovertamab vedotin in young people with relapsed or refractory DLBCL or Burkitt lymphoma	31 Mar 2029
JNJ-90014496: A phase 1/2 trial of JNJ-90014496 in people with relapsed or refractory B-cell non-Hodgkin lymphoma	29 Mar 2029
OLYMPIA-5: A phase 3 trial of odronextamab in people with relapsed or refractory follicular or marginal zone lymphoma	23 Jan 2029
MK-1026: A phase 2 trial of nemabrutinib (MK-1026) in people with certain types of relapsed or refractory non-Hodgkin lymphoma	4 Jan 2029
ReVenG: A phase 2 trial of venetoclax and obinutuzumab in people with relapsed chronic lymphocytic leukaemia	1 Jan 2029
BOOST: studying samples from stem cell transplant donors and recipients to improve transplant success rates and reduce side effects	31 Dec 2028
J2N-MC-JZNX: A phase 2 trial of pirtobrutinib in people with relapsed or refractory CLL/SLL	1 Dec 2028
TERZO: A phase 3 trial of duvelisib in relapsed or refractory nodal T-cell lymphoma with follicular helper phenotype	1 Dec 2028
CARAMEL: A phase 2 trial of acalabrutinib and rituximab in people with untreated mantle cell lymphoma	1 Dec 2028
ZEBRA: a phase 2 trial of zanubrutinib and rituximab in people with mantle cell lymphoma	1 Oct 2028
PORTAL: a phase 2 trial testing polatuzumab vedotin, obinutuzumab and glofitamab in adults with relapsed or refractory large B-cell lymphoma	30 Jul 2028
Micro-CART: A study investigating infection risk and the microbiome in blood cancer patients treated with CD19 CAR-T therapy	31 May 2028
BGB-16673-304: A study to evaluate the safety and efficacy of BGB-16673 compared to pirtobrutinib in adults with relapsed/refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma	17 Apr 2028
GLOBRYTE: A phase 3 trial of glofitamab in people with relapsed or refractory mantle cell lymphoma	31 Mar 2028
Lumi-NHL: A phase 1 and 2 trial of AZD4512 in people with relapsed or refractory B-cell non-Hodgkin lymphoma	1 Mar 2028
M24-287: A Study to evaluate the risk of tumor lysis syndrome in adults receiving oral venetoclax combination with obinutuzumab or acalabrutinib for chronic lymphocytic leukaemia (CLL)	1 Mar 2028
NX-1607: A phase 1 study of NX-1607 in adults with advanced solid tumours	28 Feb 2028
Soundtrack-E: A phase 1 and 2 trial of AZD0486 in people with B-cell lymphomas	28 Feb 2028
PRiZM+: A phase 1 trial of zanubrutinib in people with relapsed or refractory primary central nervous system lymphoma	31 Jan 2028
Keynote-D20: BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies	15 Jan 2028
BRUIN-CLL-314: A phase 3 trial of pirtobrutinib compared to ibrutinib in adults with chronic lymphocytic leukaemia	1 Jan 2028
NX-5948-301: A phase 1 study of a new treatment called NX-5948 in adults with relapsed or refractory B-cell lymphoma	1 Jan 2028
GLORA: A study to investigate the efficacy and safety of lisaftoclax in combination with BTK inhibitors in CLL/SLL	31 Oct 2027
waveLINE-003: A trial testing zilovertamab vedotin (MK-2140) in people with relapsed or refractory diffuse large B-cell lymphoma	24 Sep 2027
CAN3001: A long term study of ibrutinib	31 Aug 2027
MoTD: A study to explore T-cell depletion	23 Aug 2027
SEARCH: Screening for early detection of second lung cancer after radiotherapy or chemotherapy for Hodgkin lymphoma	1 Jun 2027
STELLAR: a phase 2 trial of acalabrutinib in people with Richter syndrome	31 May 2027
DTP3: A phase 1/2 trial of DTP3 in people with relapsed or refractory diffuse large B cell lymphoma (DLBCL)	31 Mar 2027
CCS1477-02: a phase 1/2a study of CCS1477 in blood cancers, including relapsed or refractory non-Hodgkin lymphoma	31 Mar 2027
iMATCH: a study to develop a quality of life questionnaire for people having CAR-T therapy	31 Mar 2027
PROCLIPI: a study aiming to identify factors important in predicting the outcome of cutaneous (skin) lymphomas, mycosis fungoides and Sezary syndrome	1 Mar 2027
MOGAT: A phase 2 trial of mogamulizumab in cutaneous T-cell lymphoma	1 Jan 2027
CRUK17062: A trial of inobrodib for some types of blood cancer	31 Dec 2026
STP938: A phase 1/2 study of STP938 for adults with relapsed or refractory B-cell and T-cell lymphomas	31 Dec 2026
JNJ-80948543: A phase 2 trial testing JNJ-80948543 in adults with relapsed and refractory DLBCL	21 Sep 2026
NuTide:701: a phase 1 trial to find the best dose and test the safety of a new drug called NUC-7738 in people with advanced solid tumours or lymphoma	1 Aug 2026
BASILICA-A: A study into why anaplastic large cell lymphoma sometimes occurs after breast implants	30 Jun 2026